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ABSTRACT Small nucleolar RNAs (snoRNAs) play a key role in ribosomal RNA (rRNA) biogenesis. Box C/D 
snoRNAs guide the site-specific 2’-O-ribose methylation of nucleotides in rRNAs and small nuclear RNAs 
(snRNAs). A number of box C/D snoRNAs and their fragments have recently been reported to regulate post-
transcriptional modifications and the alternative splicing of pre-mRNA. Artificial analogues of U24 snoRNAs 
directed to nucleotides in 28S and 18S rRNAs, as well as pre-mRNAs and mature mRNAs of human heat shock 
cognate protein (hsc70), were designed and synthesized in this study. It was found that after the transfection of 
MCF-7 human cells with artificial box C/D RNAs in complex with lipofectamine, snoRNA analogues penetrated 
into cells and accumulated in the cytoplasm and nucleus. It was demonstrated that the transfection of cultured 
human cells with artificial box C/D snoRNA targeted to pre-mRNAs induce partial splicing impairments. It 
was found that transfection with artificial snoRNAs directed to 18S and 28S rRNA nucleotides, significant for 
ribosome functioning, induce a decrease in MCF-7 cell viability.
KEYWORDS small nucleolar box C/D RNAs; post-transcriptional RNA modification; alternative splicing of pre-
mRNA.
ABBREVIATIONS rRNAs – ribosomal RNAs; snoRNAs – small nucleolar RNAs; snRNAs – small nuclear RNAs; 
RT-PCR – reverse transcription polymerase chain reaction; RP-HPLC – reverse phase high-performance liquid 
chromatography; MTT – 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; FAM – carboxyfluo-
rescein.
INTRODUCTION
the class of small nucleolar rnAs (snornAs) consists 
of two major families: box c/D rnAs and box H/AcA 
rnAs. these rnAs act as a recognizing and targeting 
element in rnA–ribonucleoprotein complexes and par-
ticipate in the modification of nucleotides in eukaryotic 
ribosomal rnAs. the rnAs belonging to the box c/D 
rnA family guide the 2’-O-methylation of rrnA nu-
cleotides. Box c/D rnAs contain conserved structural   
elements, cuGA (box D) and ruGAuGA (box c), near 
the 5’ and 3’ termini, respectively. the box c/D rnAs 
possess a  guide sequence region (a sequence comple-
mentary to the region of an rnA target). certain rnAs 
contain two  guide sequences and two box c/D pairs (c, 
D, c’, and D’) [1].
Cavaille J. et al. [2] demonstrated that if the rnA 
contains structural  elements determining its member-
ship in the family of box c/D rnAs, then it is suffi-
cient to have the corresponding region of the box c/D 
snornA (complementary to the rnA target) in order 
to determine the methylation target. It was shown that 
2’-O-methylation of rnA nucleotides without natural 
2’-O-methyl groups can be guided by analogues of box 
c/D rnAs [2].
One of the key approaches to the study of the proper-
ties of box c/D rnAs is the design of DnA constructs 
that are expressed in a cell yielding either short non-nat-
ural snornAs or pre-mrnA fragments, the processing 
of which results in the formation of snornAs targeted 
to the pre-specified rrnA nucleotides [2]. this approach 
was used to design methods for the directed nucleotide 
modification in eukaryotic rnAs and for mapping func-
tionally important rrnA sites, which are sensitive to reSeArcH ArtIcLeS
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de novo 2’-O-methylation [3, 4]. the range of targets for 
artificial small nucleolar rnAs is not confined to rrnAs 
and snrnAs. the participation of snornAs in mrnA 
maturation is of increasing interest. It has already been 
revealed that box c/D rnAs can interact both with the 
products of transcription by rnA-polymerase I localized 
in the nucleolus and with rnA-polymerase II products 
[2]. Moreover, small nucleolar rnA HBII-52 (MBII-52) 
takes part in the processing of pre-mrnA of the serot-
onin receptor 5-Ht2cr [5, 6]. thus, the structure of box 
c/D small nucleolar rnAs is a promising basis for the 
development of constructs for the directed regulation of 
gene expression in human cells.
the effect of synthetic analogues of natural box c/D 
rnAs on pre-mrnA-target splicing and processing of 
18S and 28S rrnA in human cells was investigated in 
this study. the analogues of human u24 box c/D rnA 
directed to pre-mrnA of human heat shock cognate 
protein hsc70 and human rrnA were designed. the 
transfection of the McF-7 cell line (human breast ade-
nocarcinoma cells) with synthetic analogues was shown 
to result in a partial disruption of splicing (the elimi-
nation of an exon from the pre-mrnA-target). It was 
found that the transfection of McF-7 cells with syn-
thetic analogues of box c/D rnAs directed to rrnAs 
induces a decrease in cell viability.
EXPERIMENTAL
Artificial box C/D RNAs synthesis
Synthetic analogues of box c/D rnAs were obtained 
via the in vitro transcription of Pcr-amplified DnA 
templates with t7 rnA polymerase (Fermentas, 
Lithuania).
Transfection of MCF-7 cells with synthetic 
RNAs. Isolation of total cellular RNA
McF-7 cells (from the russian cell culture collection of 
vertebrates, Institute of cytology, russian Academy 
of Sciences, St. Petersburg) were cultured in an IMDM 
medium with 10 mM L-glutamine and 40 µg/ml of gen-
tamicin in the presence of 10% fetal bovine serum at 37оС. 
Synthetic analogues of box c/D rnAs were pre-incu-
bated with the lipofectamine reagent (Invitrogen, unit-
ed States) according to the manufacturer’s protocol and 
were subsequently added to the culture medium. After 
the McF-7 cells had been incubated for 18 h, total rnA 
was isolated using the trizol reagent (Invitrogen, united 
States) according to the manufacturer’s protocol.
Isolation of cytoplasmic and nuclear 
fractions of MCF-7 cell lysate
upon completion of incubation, the McF-7 cells were 
ice-cooled. the medium was collected. the cells were 
washed twice with phosphate buffered saline (PBS) 
and lysed on ice for 10 min (0.5% triton X-100 in 
buffer A containing 150 mM nacl, 50 mM tris-Hcl 
pH 7.5, 10 mM eDtA). the lysate was suspended and 
coated onto a 10% sucrose solution in buffer A, fol-
lowed by centrifugation for 20 min at 600 g. the isola-
tion of rnA from the supernatant (the cytoplasmic 
fraction of McF-7) and nucleolar precipitate sus-
pended in buffer A was carried out using the trizol 
reagent. rnA concentrations in the samples were de-
termined spectrophotometrically (λ = 260 nm), tak-
ing into account the extinction coefficient for rnA 
(ε260 = 25 l/mol cm). 
Analysis of pre-mRNA HSPA8 
splicing variants by RT-PCR
the reverse transcription of pre-mrnA in the HSPA8 
and cDnA amplification was performed in the reac-
tion mixture for rt-Pcr “real Best Master Mix rt” 
(Vektor-Best, novosibirsk, russia) using the primers 
hsp2.1 (5’-ActGAAcGGttGAtcGGtGA-3’) and 
hsp8.2 (5’-AGAtGAGcAcGtttctttct-3’). the 
products were analyzed in a 4% polyacrylamide gel. 
the quantity of amplification products in the gel was 
ascertained using the Gel-Pro Analyzer 3.1 software. 
Sanger sequencing was performed using fluorescently 
labelled terminators of DnA-polymerase in the BigDye 
3.1 mixture, followed by the separation of DnA on an 
ABI3100 analyzer (Applied Biosystems, Inter-Institute 
Sequencing centre, Siberian Branch of the russian 
Academy of Sciences).
Fluorescently labelled box C/D RNA 
synthesis and analysis of the accumulation of 
fluorescently labelled RNA in human cells
Fluorescently labelled rnA was obtained via in vitro 
transcription  by t7 rnA polymerase (Fermentas, 
Lithuania) using Flu-12-utP (Biosan, novosibirsk, 
russia). the rnA transcript was isolated via ion-
pair rP-HPLc on a Milichrome A-02 liquid chroma-
tograph using the ProntoSIL-120-5-c18 sorbent and 
a 2.0 × 7.5 mm column. the accumulation of fluores-
cently labelled rnA in McF-7 cells was analyzed via 
fluorescence microscopy (the centre for collective use 
of Microscopic Analysis of Biological Objects, Siberian 
Branch of the russian Academy of Science). For this 
purpose, 3 × 104 McF-7 cells were seeded onto a slide 
plate of the culture Slide chamber (BD Falcon, united 
States), then they were transfected with fluorescently 
labelled rnA after 24 h, followed by incubation for 18 
h. the medium was removed post-incubation. the cells 
were washed twice with PBS; the specimens were em-
bedded into a drop of the DAPI/Antifade dye (Milli-
pore, united States) and covered with a cover slip. the 34 | ActA nAturAe |  VOL. 4  № 1 (12)  2012
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specimens were analyzed on an Axioskop 2 Plus micro-
scope (carl Zeiss, Germany).
Analysis of 2’-O-methylation of 
G1702 of the 18S rRNA
2’-O-methyl groups of rrnA were detected via par-
tial alkaline hydrolysis as previously described in [7]. 
the total rnA of the McF-7 cells (2.5–5.0 µg) was 
incubated in a 50 mM na2cO3 solution (pH 9.0) for 
18 min at 90оС. the hydrolysis products were  re-
covered by ethanol precipitation. reverse tran-
scription  was  carried  out  using  primer  18.1702 
(5’-GccGAtccGAGGGcctcAct-3’), complemen-
tary to the region 1731–1750 of the 18S rrnA, using 
M-MLV reverse transcriptase (Biosan, novosibirsk, 
russia). the rrnA region was sequenced via reverse 
transcription in the presence of ddntP, according to 
[8].
Analysis of MCF-7 cell viability via the MTT assay
In order to analyze the effect of the analogues of box 
c/D rnAs on the viability of McF-7 cells, the cells 
were cultured in a 96-well plate (3 × 104 cells per well). 
After 24 h, the rnA–lipofectamine complex was added 
to the culture mixture until concentrations of 3.0, 10.0, 
and 70.0 nM were obtained. McF-7 cells were incubat-
ed with rnA for 3 days; the Mtt solution in PBS was 
subsequently added to the medium until a final con-
centration of 0.5 mg/ml. the mixture was incubated 
at 37°С for 90 min. After the medium was removed, 
Mtt-formazan crystals were dissolved in 100 µl of 
isopropanol. the absorbance of the solution was deter-
mined (λ = 570 nm, control at λ = 620 nm) on an Apollo 
8 LB 912 multichannel spectrophotometer (Berthold 
technologies, Germany). the data were presented as 
a decrease in viability (100% – Mtt index) against the 
control (cells incubated under identical conditions with 
lipofectamine alone).
RESULTS
the effect of the synthetic analogues of box c/D rnAs 
on rnA processing in human cells was studied using 
the designed analogues of human natural u24 box c/D 
rnA. Human u24 rnA contains cuGA and AuGAu-
Gu (GuGAuGA) sequences (for D and c (c’) boxes, re-
spectively) and two guide sequences directing the 2’-O-
methylation of c2338 and c2352 in 28S rrnA (Fig. 1A) 
[9]. the resulting analogues contain conserved regions 
that are identical to u24 box c/D rnA and the regions 
complementary to those of the rnA-targets designed 
so that the target nucleotide in the rnA target was 
complementary to the fifth nucleotide upstream from 
box D (D’) (cuGA) of the analogue of box c/D rnA [2]. 
All the resulting rnAs contained two sets of box c/D 
rnA (c/D and c’/D’, respectively) and thus two  guide 
sequences (Fig. 1B).
One of the guide sequences (the D-box-dependent 
one) was directed to pre-mrnA nucleotides of the 
HSPA8 gene encoding the human heat shock cognate 
protein (hsc70). Suppressing the expression of hsp-70-
related proteins, including the hsc70 protein, results in 
the death of cultured cancer cells. the HSPA8 gene is 
considered to be a promising target for gene-targeted 
cancer therapy [10]. nucleotides, the modification of 
which may have a negative effect on the excision of the 
second intron upon pre-mrnA splicing, were selected 
for application as targets of the synthetic analogues: 
adenosine – the splicing branch point, splice donor and 
splice acceptor sites, the first and the last intron nucle-
otides. the second  guide sequence (the D’-dependent 
sequence) was directed to G1702 in human 18S rrnA. 
the sequences of the analogues of box c/D rnAs are 
specified in Table 1.
It was ascertained via the transfection of McF-7 
cells with synthetic analogues of box c/D rnA and 
analysis of the variants of the alternative splicing of 
pre-mrnA of the HSPA8 gene that both variants of 
alternative splicing of this pre-mrnA (the major and 
minor ones) can be identified in the control McF-7 cells 
А
B
box C  box D’  box C’  D box
box C  box D’  box C’  box D
Guide sequences 
Primer 1
 Template
Primer 2
PCR
 TATA-box
DNA template 
Transcription by T7 bacteri-
ophage RNA polymerase
Guide sequence  
directed to the G1702 
of 18S rRNA
Variable guide 
sequence 
AUGAUGU CUGA GUGAUGA CUGA
Fig.1. (A) – Structure of U24 box C/D RNA;  
(B) – Scheme of synthesis of the artificial box C/D RNA.reSeArcH ArtIcLeS
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(Fig. 2, lane K). It was demonstrated via the sequencing 
of these forms that they differ by either the presence 
or absence of the second exon. the content of the minor 
form, i.e., the form without the second exon, increases 
in the cells transfected with synthetic box c/D rnAs 
directed to the nucleotides that are key ones for pre-
mrnA splicing (Fig. 2A, lanes 1–5). thus, it was found 
that the analogues of box c/D rnAs directed to the se-
lected pre-mrnA nucleotides of the HSPA8 gene have 
an impact on the pre-mrnA target splicing and result 
in the excision of the second exon.
the transfection efficiency, distribution, and sta-
bility of the synthetic analogues of box c/D rnAs 
were assessed via rt-Pcr of nuclear and cytoplas-
mic rnA of the McF-7 cells transfected with PM.8 
rnA. It is clear from the data shown in Fig. 3 that, 3 h 
after the passive transfection of the cells with PM.8 
rnA in the absence of lipofectamine, rnA could be 
detected neither in the nuclear nor in the cytoplasmic 
fraction of McF-7 cells (Fig. 3, lanes 1, 7). After the 
cells were transfected with the analogue of box c/D 
rnA in the presence of lipofectamine, PM.8 rnA was 
found both in the cytoplasmic and nuclear fractions 
even 26 h post-transfection (Fig. 3, lanes 5, 11). All 
these facts lead one to the conclusion that synthetic 
box c/D rnAs in the presence of lipofectamine can 
efficiently penetrate into the cell cytoplasm and nu-
cleus, where they can participate in the processing of 
the pre-mrnA-target. 
the rt-Pcr data are in close correlation with the 
results of the analysis of the distribution of FAM-la-
belled PM.8 rnA in McF-7 cells via fluorescent micro-
Table 1. Synthetic analogues of U24 box C/D RNA directed to the key nucleotides involved in the splicing of pre-mRNA 
of the gene HSPA8
notation nucleotide sequence* target nucleotide  
in the  hsc70 pre-mrnA
РМ.7 5’-UGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGAGAG 
AUGGUGAUGACAAAUGAAAACACUUUCAAUCUGAUGCA-3’ Adenosine – splicing branch point
РМ.8 5’-UGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGAGAG 
AUGGUGAUGAAAAUUAGGAACUCACCAAAACUGAUGCA-3’ Splice donor site
РМ.9 5’-UGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGAGAG 
AUGGUGAUGAAAAUUAGGAACUCACCAAACUGAUGCA-3’ First intron nucleotide
РМ.10 5’-UGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGAGAG 
AUGGUGAUGAACAGAUGCCAAACGUCUGAUCUGAUGCA-3’ Splice acceptor site
РМ.11 5’-UGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGAGAG 
AUGGUGAUGAUACAGAUGCCAAACGUCUGACUGAUGCA-3’ Last intron nucleotide
*AUGAUGU – conserved elements of box C/D RNA; A – nucleotides that are complementary to the target nucleotide.
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Fig.2. Influence of U24 RNA analogues on pre-mRNA 
HSPA8 splicing. (A) – RT-PCR products of pre-mRNA 
HSPA8 splicing variants. The lanes correspond to the 
cDNA amplification products of 1 – 5 cells transfected 
with analogues PM.10, PM.7, PM.8, PM.9, PM.11, 
respectively; K – control MCF-7 cells incubated with lipo-
fectamine. PCR products were analyzed on a 4% native 
polyacrylamide gel. Pre-mRNA HSPA8 splicing variants 
are schematically represented. (B) – the ratio between 
the yields of the PCR products of the minor and major pre-
mRNA hsc70 splicing variants. РМ.7 – РМ.11 – the cells 
were transfected with box C/D RNA analogues РМ.7 
– РМ.11, respectively. K – control MCF-7 cells were 
incubated with lipofectamine alone.36 | ActA nAturAe |  VOL. 4  № 1 (12)  2012
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scopy. thus, after the cells are incubated in a medium 
with FAM-labelled PM.8 box c/D rnA in complex 
with lipofectamine, rnA is captured, internalized, and 
then distributed both over the cytoplasm and the cell 
nucleus (Fig. 4).
It is known that rrnA nucleotides, which directly 
participate in the formation of ribosomal active sites 
or are located in close proximity to them, are more 
likely to undergo post-transcriptional modifications ( 
pseudouridylation and 2’-O-methylation) [11]. these 
data permit the assumption that the post-transcrip-
tional modifications have a substantial effect on the 
rrnA structure during the assembly process and 
eventually determine the ribosomal functionality 
[11–13].
the induction of 2’-O-methylation of the target of 
the second guide sequence (G1702 of the 18S rrnA) 
was analyzed in order to assess the ability of an ana-
logue of box c/D rnA to direct rrnA modification. 
Since G1702 is one of the key nucleotides of the de-
coding site of human ribosomes, it was selected to be 
the target [14]. no additional 2’-O-methylated nucle-
otide at position G17012 of 18S rrnA was detected in 
the structure of rrnAs from the McF-7 cells trans-
fected with synthetic analogues via partial alkaline 
hydrolysis (Fig. 5). the presence of the 2’-O-methyl-
ated nucleotide within rrnA results in a decrease in 
the yield of the cDnA product (among the products 
of reverse transcription of statistically hydrolyzed 
rrnA), the length of which is determined by the po-
sition occupied by a nucleotide that is downstream 
adjacent to the 2’-O-methylated nucleotide [8]. How-
ever, it is clear from Fig. 5 that the yield of the cDnA 
transcript corresponding to the 2’-O-methylated 
G1702 of 18S rrnA does not decrease as a result of 
Incubation time, h  3  3  21  21  26  21  3  3  21  21  26  21
Analogue of box C/D RNA  +  +  +  +  +  -  +  +  +  +  +  -
Lipofectamine  -  +  -  +  +  +  -  +  -  +  +  +
Bp
400
300
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М     123456789101112
Nuclear fraction   Cytoplasmic fraction
Fig.3. Integrity of artificial box C/D RNA within MCF-7 cells. Human cells were transfected with the PM.8./lipo-
fectamine complex (2,4,5,8,10,11), or PM.8 without lipofectamine (1,3,7,9) for the time indicated. Control cells 
were incubated with lipofectamine alone (6,12). RT-PCR products of RNA isolated from the nuclear (1–6) or cytoplas-
mic fraction (7–12). DNAs were analyzed on a 2% agarose gel. M – DNA molecular weight marker.
А B c
D E F
Fig.4. Accumulation of box C/D RNA analogue PM.8 
within MCF-7 cells. Fluorescence microscopy images of the 
transfected (A–c) and control cells (D–F): (A,D) – green 
filter ( FAM-labelled box C/D RNA analogue); (B,E) – blue 
filter (staining with DAPI); (c,F) – merged images.reSeArcH ArtIcLeS
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the transfection of human cells with any analogue of 
box c/D rnAs.
the effect of synthetic analogues of box c/D rnAs 
on the post-transcriptional modification of rrnAs in 
human cells was analyzed using the designed and ob-
tained analogues of u24 box c/D rnA, whose first 
guide sequence was directed to the nucleotides of hu-
man 18S and 28S rrnA. the nucleotide sequences of 
the analogues of box c/D rnAs are listed in Table 2. 
the targets selected are the key nucleotides of the ri-
bosomal functional sites: u1827 of the 18S rrnA can be 
found in the ribosomal decoding centre; G4499, u4500, 
and u4502 of the 28S rrnA, in the peptidyl transferase 
centre [3, 4]. the second guide sequence of the ana-
logues (the D’-box-dependent one) is directed to G1702 
of the human 18S rrnA (Table 2).
A comparative analysis of the effect of the analogues 
of box c/D rnAs on McF-7 cell viability was per-
formed. the effect of the analogues of box c/D rnA 
was assessed after the cells were incubated in a me-
dium with initial rnA concentrations of 3.0, 10.0, and 
70.0 nM. It is clear from Fig. 6 that the greatest reduc-
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Fig.5 . Analysis of 2’-O-methylation 
of G1702 in 18S rRNA. RT products: 
(1–5) – rRNA isolated from MCF-7 
cells transfected with box C/D RNA 
analogues PM.7–PM.11, respective-
ly; (6) – rRNA isolated from control 
MCF-7 cells; (7–10) – sequencing of 
the corresponding region of human 
18S rRNA. RT products were sepa-
rated on a 12% denaturing polyacry-
lamide gel. The left arrow points to 
the position of the cDNA product, 
whose diminishing intensity could be 
an indicator of the 2’-O-methylation 
of G1702 in 18S rRNA.
Table 2. Synthetic analogues of U24 box C/D RNA directed to the nucleotides in human 18S and 28S rRNA
notation nucleotide sequence* target nucleotide  
in human rrnA
РР.1827 5’-GGGUGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGA 
GAGAUGGUGAUGACCUUGUUACGACUUUCUGAUGCACCC-3’ u1827 18S
РР.4499 5’-GGGUGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGA 
GAGAUGGUGAUGAACGGUCUAAACCCAGCUGAUGCACCC-3’ G4499 28S
РР.4500 5’-GGGUGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGA 
GAGAUGGUGAUGAGACGGUCUAAACCCACUGAUGCACCC-3’ u4500 28S
РР.4502 5’-GGGUGCAGAUGAUGUAAAAUAGCGACGGGCGGUGCUGA 
GAGAUGGUGAUGAACGACGGUCUAAACCCUGAUGCACCC-3’ u4502 28S
* See note in Table1.38 | ActA nAturAe |  VOL. 4  № 1 (12)  2012
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Fig.6. Influence of artificial box С/D RNAs on the viability 
of MCF-7 cells. The MCF-7 cells were transfected with 
the RNA/lipofectamine complex and incubated for three 
days. The data represent the viability reduction (the aver-
age decrease in the MTT index and SD in 3 independent 
experiments) of cells treated with 3.0 nM (green); 10.0 
nM (blue); and 70.0 nM (red) of RNA. The relative reduc-
tion in viability by 0% corresponds to the MTT index of the 
cells treated with lipofectamine alone.
tion in viability (> 35%) was induced by box c/D rnAs 
directed to u1827 of the 18S rrnA, G4499, u4500, and 
u4502 of the 28S rrnA. Meanwhile, the decrease in 
cell viability and proliferation caused by the analogues 
of u24 rnA, whose first guide sequence was directed 
to pre-mrnA of the hsc70 protein, was less than 22% 
(Fig. 6, РМ.7 and РМ.8).
McF-7 cells were transfected with the analogues 
of box c/D rnA (Table 2) in order to analyze the in-
duction of de novo 2’-O-methylation of target nu-
cleotides; 2’-O-methylated rrnA nucleotides were 
detected by the partial alkaline hydrolysis method. It 
was ascertained that the contribution of rrnA forms 
containing the 2’-O-methylated target nucleotide in 
the total rnA pool of the transfected McF-7 cells 
was lower than the sensitivity threshold of the de-
tection technique.
the data relating to the changes in cell viabil-
ity under the action of box c/D rnA, combined with 
the observed absence of the modification of the tar-
get nucleotides, allows one to assume that the effect 
of the analogues on human cells can be stipulated by 
the participation of box c/D rnAs not only in 2’-O 
methylation of rrnA nucleotides, but in other stages 
of post-transcriptional rrnA processing and ribosomal 
assembly, as well.
DISCUSSION
the conserved structural elements of box c/D rnA, 
namely, c/c’ (ruGAuGA) and D/D’ (cuGA) boxes, 
and the guide sequence  ensure the ability of these 
rnAs to participate in the formation of a catalytic 
complex with proteins of the methyltransferase com-
plex and direct 2’-O-methylation of a pre-specified 
nucleotide [1, 2, 15]. the guide sequence  region of box 
c/D rnAs is a sequence consisting of 10–21 nucle-
otides, which is complementary to the rnA target; 
the nucleotide to be methylated is complementary to 
the fifth nucleotide of snornA  upstream from the D 
box [7].
rrnAs and snrnAs are the major targets of box 
c/D rnAs in eukaryotic cells. Meanwhile, snornAs 
participating in pre-mrnA processing have been 
detected [6]. It was ascertained earlier that box c/D 
rnAs can interact with the transcripts synthesized by 
rnA polymerase II and guide 2’-O-methylation of a 
pre-specified nucleotide of the rnA target. the effi-
ciency of the target nucleotide modification is substan-
tially lower than that of the rnA targets synthesized in 
the nucleus by rnA polymerase I [2]. Moreover, it is a 
known fact that the chemical modification (in particu-
lar, methylation) of the 2’-OH groups of the oligonucle-
otides participating in pre-mrnA splicing significantly 
affects the efficiency of pre-mrnA maturation stages 
[16]. therefore, the analogues of box c/D rnAs direct-
ing the 2’-O-methylation of pre-mrnA nucleotides are 
a promising model for the design of agents for splicing 
regulation.
the analogues of u24 small nucleolar box c/D rnA 
directed to pre-mrnA nucleotides of the HSPA8 gene 
encoding heat shock cognate protein (hsc70) were de-
signed and obtained in the present study (Fig. 1). It was 
ascertained that the transfection of human cells with 
synthetic analogues of box c/D rnA directed to the 
splice donor and splice acceptor sites of the second in-
tron, adenosine the splicing branch point, the first and 
the second nucleotides of the first intron of pre-mrnA 
of the HSPA8 (Table 1) results in an increase in the 
amount of the splicing product of pre-mrnA without 
the second exon (Fig. 2). two key mechanisms can be 
proposed for the influence of the analogues of box c/D 
rnA on pre-mrnA target processing: 2’-O-methyl-
ation of the target nucleotide and complementary in-
teraction between the antisense region of the box c/D 
rnA with the target rnA. Both pathways may theo-
retically result in the inhibition of certain splicing steps 
and, consequently, in a change in variants of alterna-
tive splicing of the pre-mrnA target.
the methods for detection of 2’-O-methylated nu-
cleotides, which are currently in widespread appli-
cation, do not allow to reveal these modifications in reSeArcH ArtIcLeS
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mrnA and pre-mrnA with an adequate level of ef-
ficiency. therefore, it cannot be unambiguously stated 
whether the methylation of the nucleotide target actu-
ally occurs, and whether or not the effect on splicing is 
caused by 2’-O-methylation of the pre-mrnA target. 
the key points of pre-mrnA splicing are sensitive to 
the modifications of the 2’-OH groups of ribose resi-
dues to different extents [16]. the resulting data do not 
permit one to claim considerable differences in the ef-
ficiency of splicing suppression by the analogues of box 
c/D rnA directed to various pre-mrnA nucleotides; 
therefore, the possibility cannot be excluded that the 
changes in the ratio between the forms of the alterna-
tive splicing of the pre-mrnA target being observed 
are induced by splicing inhibition by antisense rnA via 
the mechanism that was described for various oligonu-
cleotide derivatives [17–19].
In order to participate in splicing, artificial rnA has 
to interact with the pre-mrnA target inside the nu-
cleus. It was demonstrated that the analogues of box 
c/D rnA in the presence of lipofectamine are capable 
of efficient penetration into human cells (Figs. 3, 4). It 
is clear from Fig. 3 that the analogue of box c/D rnA 
was reliably detected by rt-Pcr 26 h following the 
single transfection in the presence of lipofectamine in 
the nuclear and cytoplasmic rnA fractions of McF-7 
cells. the resulting data attest to the fact that the arti-
ficial box c/D rnAs are potentially available for inter-
action with rnA targets located inside the nucleus. the 
accumulation of synthetic rnA in cells was confirmed 
via fluorescence microscopy (Fig. 4). Furthermore, it 
was ascertained that the synthetic analogues of box 
c/D rnA in the presence of lipofectamine can be ef-
ficiently conserved and detected via rt-Pcr in human 
cells 72 h after the single transfection (the data are not 
illustrated). Meanwhile, in the case of transfection in 
the absence of lipofectamine, synthetic rnAs cannot 
be detected in human cells via rt-Pcr as early as 3 h 
after having been introduced into the culture medium 
(Fig. 3).
For all the analogues of u24 snornAs obtained, 
one of the two guide sequences  was designed so as to 
direct the 2’-O-methyaltion of G1702 in human 18S 
rrnA (Table 1). It was shown earlier that the trans-
fection of human cells with synthetic analogues of 
box c/D rnAs directed to rrnA nucleotides (Table 2) 
induces the termination of reverse transcription on 
the target nucleotides [20, 21]. However, no additional 
2’-O-methyl group at the specified position was de-
tected from the analysis of 2’-O-methylation of G1702 
in 18S rrnA of the cells transfected with the ana-
logues of box c/D rnA via partial alkaline hydroly-
sis (Fig. 5). neither of the de novo 2’-O-methylation 
of rrnA nucleotides – the targets of the analogues 
specified in Table 2 (after cell transfection with the 
corresponding rnAs) – was revealed. Meanwhile, the 
positions of a number of known 2’-O-methylated nu-
cleotides in human rrnA was successfully determined 
using this method.
the following data are to be given additional consid-
eration in order to interpret the absence of a modifica-
tion of the target nucleotides (with an exception for 
the known limitations of the analysis methods [8]). It 
is a known fact that the participation of box c/D rnA 
in the 2’-O-methylation of human cell rrnA is possi-
ble only provided that this rnA can be recognized by 
the proteins that are the subunits of the methyltrans-
ferase complex (namely, fibrillarin, nOP56p, nOP58p, 
and 15.5 kDa) and that the complex is formed with the 
participation of box c/D rnAs [22–24]. therefore, the 
low yield of the targeted 2’-O-methylation observed 
can be explained by the low efficiency of the assem-
bly of catalytically competent methyltransferase com-
plexes with the analogues of box c/D rnA. Moreover, 
it was previously shown by Liu B. et al. [3, 4, 25] (who 
studied the transfection of yeast cells with DnA con-
structs encoding the analogues of box c/D rnA) that 
expression and maturation of artificial snornAs take 
place in the transfected cells. It also turned out that 
the expression of box c/D rnAs directed to a number 
of rrnA nucleotides resulted in a significant decrease 
in the proliferation rate and viability of the cells. the 
combination of the resulting data made it possible to 
arrive at a conclusion that it is 2’-O-methylation of 
rrnA nucleotides, guided by the analogues of box 
c/D rnA, that is the major reason for the influence of 
DnA constructs on the proliferation rate of the cells. 
However, for a number of box c/D rnAs [3, 4, 25], 
only a low level of 2’-O-methylation (or no modifica-
tion at all) in the target nucleotides was revealed. On 
the other hand, the post-translational modifications 
(2’-O-methylation and pseudouridilation) are known 
to occur at the stage of maturation of the 47S rrnA 
precursor [7, 26–28]. the quality of the rrnA tran-
script is verified at the stage of the assembly of func-
tional ribosomes; the incorrect nonfunctional rnA 
transcripts undergo degradation in exosomes [29]. the 
synthetic analogues of box c/D rnA are directed to 
the rrnA nucleotides immediately participating in 
the formation and functioning of the ribosomal active 
sites. Presumably, 2’-O-methylation of rrnA, guided 
by synthetic analogues of box c/D rnAs, has a sig-
nificant effect on the rrnA structure and ribosomal 
functionality; this results in a rapid degradation of 
modified rnA and its low content in the transfected 
cells [25, 29].
Despite the fact that no modification of the target 
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complementarily interact with the rrnA target, thus 
participating in the regulation of the maturation of 
rrnA transcripts and in ribosomal assembly and func-
tioning. Hence, synthetic analogues of box c/D rnA 
can participate in the vital activity of the transfected 
cells and, therefore, affect the viability and prolifera-
tion of human cells.
the effect of the analogues of box c/D rnA on the 
viability of human McF-7 cells was assessed via the 
Mtt assay. the data obtained made it possible to ar-
rive at the conclusion that cell transfection with syn-
thetic analogues, whose first guide sequence  is direct-
ed to the nucleotides of 18S and 28S rrnA (Table 2), 
results in a decrease in their viability by 36–48%; the 
initial concentration of synthetic rnA in the medi-
um being 70.0 nM (Fig. 6, РР.1827, РР.4499, РР.4500, 
РР.4502). Meanwhile, synthetic analogues simultane-
ously directed to the pre-mrnA of heat shock cognate 
protein hsc70 and on G1702 in 18S rrnA (Table 1) re-
duced the cell’s viability by only 20–25% within an in-
itial concentration range of 3.0–70.0 nM (Fig. 6, РМ.7, 
РМ.8).
the rates of proliferation and monolayer formation 
decreased considerably, and cell morphology changed 
after the McF-7 cells were transfected with synthetic 
analogues of box c/D rnA directed to u1827 in 18S 
rrnA, G4499, u4500, and u4502 in 28S rrnA. the 
rate of the decrease in viability varied for different 
analogues and depended on the target nucleotide and 
the initial rnA concentration in the culture medium 
(Fig. 6).
the difference in the influence of synthetic ana-
logues of box c/D rnA on McF-7 cell viability at-
tests to the fact that these rnAs are involved in the 
regulation of vital processes in human cells during the 
transfection. the fact that this difference is a result of 
changes in the structure of the guide sequence  allows 
one to assume that post-transcriptional processing of 
pre-rrnA is the major process modulated by the ana-
logues of box c/D rnA. It should be noted that rrnA 
nucleotides comprising the ribosomal active sites (the 
decoding and peptidyl transferase ones) were selected 
as targets (Table 2). It was shown earlier by Liu B. et al. 
[3, 4, 25] that the expression of box c/D rnAs directed 
to these nucleotides in yeast cells induces the suppres-
sion of their growth and results in the partial degrada-
tion of rrnA.
the suppression of human cell viability induced by 
the analogues of box c/D rnA attests to the fact that 
they participate in the regulation of the viability proc-
ess of the transfected cells. the fact that no target nu-
cleotide modification occurred allows one to put for-
ward a hypothesis that the analogues of box c/D rnA 
directed to rrnA are weakly involved into the 2’-O-
methylation of rrnA nucleotides; however, there is a 
presumption that they participate in the other stages of 
post-transcriptional rrnA processing and in ribosome 
maturation.
CONCLUSIONS
It has been shown in this study that the transfection 
of McF-7 cells (human breast adenocarcinoma cells) 
with synthetic analogues of box c/D rnA directed to 
pre-mrnA nucleotides of heat shock cognate protein 
hsc70 results in the disruption of splicing of the pre-
mrnA target. the transfection of McF-7 cells with 
analogues of box c/D rnA directed to the nucleotides 
in 18S and 28S rrnA that play the key role in ribos-
ome functioning induces a decrease in cell viability. the 
data obtained attest to the high potential of designing 
constructs for the regulation of human gene expression 
and translation based on the snornA structure.  
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